Biotechnology Industry Research Assistance Council (BIRAC)

Empowering India’s innovation ecosystem! At Amazon SAMBhav 2024, Hon’ble Dr. Jitendra Singh spotlighted startups as the driving force behind Viksit Bharat 2047. At BIRAC, we’re proud to foster the entrepreneurial spirit that’s shaping a brighter, self-reliant India. #StartupIndia #InnovationForIndia #ViksitBharat2047 #BIRAC Read more: https://lnkd.in/ggCEYh4M 

As you are aware, the BioE3 (Biotechnology for Economy, Environment & Employment) Policy for ‘Fostering High-Performance Biomanufacturing has recently been approved by the Union Cabinet. In order to disseminate information regarding the Policy and also to discuss the thematic areas in detail, the DBT, Govt. of India in association with BIRAC, is organizing the ‘Webinar Series on the Biofoundry and Biomanufacturing Initiative’, which was inaugurated by the Secretary-DBT & Chairman-BIRAC on 14.11.2024. The third Webinar under this series focuses on, “Biomanufacturing of Smart Proteins” Time: 10:00 to 11:00 AM, Date- 13.12.2024 registration link: https://lnkd.in/gsBQ75DD or join via YouTube: https://lnkd.in/gwM9ZZKT (on first cum basis due to limited seats) Alka Sharma Dbt | Rekha Singhal | Dr. Amit K Tripathi | Ezhil Subbian

Proposals are invited to conduct Clinical Trials training #Nationalbiopharmamission Biotechnology Industry Research Assistance Council (BIRAC) is inviting eligible organization to conduct Clinical Trials training programs for the capacity building in clinical trials for biopharma sector of India. The training should focus on ensuring adherence to regulatory standards and best practices. It is expected to be a high-value, high-impact, hands-on program aimed at enhancing stakeholders’ understanding of regulatory requirements, improving the quality of clinical trials, and prioritizing patient safety. To view RFP and for Registration click on the following link: https://lnkd.in/guCHKq-n For more information, kindly visit our website: https://lnkd.in/gmeGxgYw Call Opens on: 11th Dec 2024  Last Date of Submission: 31st Dec 2024, 5PM IST.  Contact Officials: Ms. Vandana Kaushal Program Officer, NBM-BIRAC Email ID: [email protected] Dr. Chaitanya Sampat Magar Program Officer, NBM-BIRAC Email ID: [email protected] #Clinicaltrials #Regulatory #Patientsafety #DBT #ICMR #AIIMS Jitendra Kumar | Department of Biotechnology | Indian Council of Medical Research (ICMR)

Proposals are invited to conduct ISO 13485:2016 training  #Nationalbiopharmamission Biotechnology Industry Research Assistance Council (BIRAC) is inviting eligible organization to plan and conduct ISO 13485:2016 (Medical Devices) training programmes for the capacity building of medical device start-ups and companies. The planned training should be a high value and high impact training programme of an advanced level and shall be aimed at providing guidance and practical experience, promote skill development, optimizing auditing skills, planning, executing, reporting, monitoring the effectiveness and conformity to regulatory guidelines, in order to achieve successful QMS implementation in medical device sector. To view RFP and for Registration click on the following link: https://lnkd.in/gy9n8wB5 For more information, kindly visit our website: https://lnkd.in/gmeGxgYw Call Opens on: 11th Dec 2024  Last Date of Submission: 31st Dec 2024, 5PM IST. Contact Officials: Dr. Chaitanya Sampat Magar Program Officer, NBM-BIRAC Email ID: [email protected] Ms. Vandana Kaushal Program Officer, NBM-BIRAC Email ID: [email protected] #medicaldevices #training #regulatory #qualityaudit #skill development #medtechmitra #Medtech Jitendra Kumar | Department of Biotechnology | NITI Aayog | Office of the Principal Scientific Adviser to the Government of India | Institute for research in reproduction (indian council of medical research) | ISO/IEC Artificial Intelligence (AI) Central Drugs Standard Control Organization | Quality Council of India(QCI)

BIRAC’s participation at IISF 2024 has been a game-changer! Across both days, we brought together innovators, entrepreneurs, and experts to foster collaboration, share success stories, and explore funding opportunities. From interactive workshops to impactful investor discussions, we're empowering the biotech ecosystem to innovate, grow, and thrive. Together, we’re building the future of biotech in India! #BIRACParticipation #SupportStartups #IISF2024 #BiotechIndia #Innovation Jitendra Kumar

Day 2 of IISF 2024 featured the highly engaging Technical Session 4—Investor Panel Discussion! Investors, CXOs, and mentors shared insights on early-stage funding opportunities, while the BIRAC team highlighted funding programs, IP management, and capacity-building initiatives designed to support biotech startups and innovators. A perfect platform for entrepreneurs to learn, connect, and take their ventures to new heights! #Day2 #TechnicalSession4 #InvestorPanel #IISF2024 #BiotechInnovation Jitendra Kumar

Virtual Webinar Announcement “First-in-Human Lentiviral Gene Therapy Trial for Hemophilia A” 10th December from 11 am-12.30 pm. The “First-in-Human Lentiviral Gene Therapy Trial for Hemophilia A” supported by #DBT and led by CSCR, #CMC Vellore has shown successful outcome. In order to celebrate the pioneering gene therapy trial, a Virtual Webinar “First-in-Human Lentiviral Gene Therapy Trial for Hemophilia A” being organised on 10th December from 11 am-12.30 pm by Department of Biotechnology Prof. Ajay K Sood, PSA to the GoI, will deliver the Keynote Address during the Webinar. We look forward for active participation of researchers, innovators and academicians #Genetherapy #Lentiviral #Trial #Innovators #Researchers #Scholars #Hemophilia Rajesh Gokhale | Jitendra Kumar | Department of Biotechnology | DBT BIRAC | Christian Medical College (CMC), Vellore | Office of the Principal Scientific Adviser to the Government of India

National Biopharma Mission (NBM) DBT BIRAC, in collaboration with Centre of Excellence Biopharmaceutical Technology, IIT Delhi is thrilled to announce the CBT Course Series 2024 from 10-12th December 2024. 📅 Dates: 10th–12th December 2024 📍 Venue: IIT Delhi The upcoming training program will host ~500 participants, including professionals from the global biotech industry, academia, stakeholders, along with Indian and international experts. The workshop will focus on capacity building and skill development, a key component of National Biopharma Mission. Themes: 1. Upstream Bioprocessing  2. Downstream Bioprocessing 3. Analytical Characterization 4. Regulatory concepts of Biosimilars 5. Data Analytics and Industry 4.0 🔬 Why Attend? • Gain insights from global leaders. • Explore cutting-edge technologies and best practices. • Network with industry experts and stakeholders. 📌 Register Now: https://lnkd.in/g9Z_Y2Em For Queries: 📞 Swati Ojha: +91 9990918772 | 📧 [email protected] 📧 Vandana Kaushal: [email protected] 📞 Suyash Srivastava: +91 9161467142 | 📧 [email protected] #NBM #BIRAC #Biopharma #SkillDevelopment #CBT2024 #IITDelhi #Biosimilar #Vaccine #Medicaldevices Jitendra Kumar | Dr. Raj K Shirumalla | Vandana Kaushal | Anurag Rathore | Suyash Srivastava | Department of Biotechnology | Indian Institute of Technology, Delhi

Recognition for BIRAC-supported startups Wockhardt Ltd. and Bugworks Research Inc. were featured in the BBC News Article "India's 'blockbuster' drugs to take on deadly superbugs" Read more at: https://lnkd.in/eqdcx7Z8 Jitendra Kumar

Day 2 of IISF 2024 was buzzing with energy at the Pitch Session! BIRAC, in collaboration with CSIR-HQ, Venture Center-NCL, CCMB, VIBHA, and CSIR-NIIST, brought together startups to showcase their innovative solutions. This platform provided a unique opportunity to connect with investors and mentors, paving the way for the next generation of biotech breakthroughs! #Day2 #TechnicalSession3 #PitchSession #IISF2024 #BiotechInnovation Jitendra Kumar | India International Science Festival